Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats

Nephrology Dialysis Transplantation

Volumn 17, Issue 6, 2002, Pages 985-991

  Kelly, Darren J ^a,c   Wilkinson Berka, Jennifer L ^a   Ricardo, Sharon D ^b   Cox, Alison J ^a   Gilbert, Richard E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Diabetes; Kidney; Macrophage; Osteopontin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN ZINC SUSPENSION; OSTEOPONTIN; PENTOBARBITAL; PERINDOPRIL; STREPTOZOCIN; RENIN; SIALOGLYCOPROTEIN; SPP1 PROTEIN, HUMAN; SPP1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE COURSE; DRUG EFFECT; FEMALE; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; KIDNEY TUBULE CELL; LEUKOCYTE AGGREGATION; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TISSUE INJURY; TRANSGENIC ANIMAL; ANIMAL; DIABETIC NEPHROPATHY; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; GENETIC TRANSCRIPTION; GENETICS; HUMAN; KIDNEY; KIDNEY TUBULE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; KIDNEY; KIDNEY TUBULES; MACROPHAGES; OSTEOPONTIN; PERINDOPRIL; RATS; RENIN; SIALOGLYCOPROTEINS; TRANSCRIPTION, GENETIC;

EID: 0035991936     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.6.985     Document Type: Article

References (38)

1. Tubulointerstitial changes as a major determinant in the progression of renal damage
2. Structure and function of the kidney in diabetic glomerulosclerosis: Correlations between morphological and functional parameters
3. Renal interstitial expansion in insulin-dependent diabetes mellitus
4. Molecular insights into renal interstitial fibrosis
5. Macrophages in renal injury
6. The role of macrophages in diabetic glomerulosclerosis
7. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy
8. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
9. Osteopontin expression in progressive renal injury in remnant kidney: Role of angiotensin II
10. Short and long term effects of antihypertensive therapy in the diabetic rat
11. A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR)
12. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat
13. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes
14. Characterization and distribution of interstitial cell types in the renal cortex of rats
15. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats
16. Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria
17. Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis
18. Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game?
19. Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system
20. Characterization of interstitial infiltrating cells in Berger's disease
21. Structural and functional domains of osteopontin
22. Characterization of the interaction between integrins and recombinant human osteopontin
23. Receptor-ligand interaction between CD44 and osteopontin (Eta-1)
24. Osteopontin: A versatile regulator of inflammation and biomineralization
25. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo
26. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis
27. Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin
28. Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis
29. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria
30. Regulation of proximal tubular osteopontin in experimental hydronephrosis in the rat
31. Angiotensinogen and AT(1) antisense inhibition of osteopontin translation in rat proximal tubular cells
32. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulo-interstitial fibrosis
33. Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells
34. Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation
35. Osteopontin regulation in cultured rat renal epithelial cells
36. Transforming growth factor-β in diabetic nephropathy
37. Aberrant glomerular expression of type I collagen in experimental diabetes: Amelioration with renoprotective therapy
38. Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin